Each 0.01mL (1 unit on a U-100 insulin syringe) contains approximately 267mcg of total peptide
Many insurers are pulling coverage for GLP-1 drugs due to their high price, forcing patients to stop treatment even when it works
A study published in Nature found that over four years, patients taking semaglutide lost an average of 10.2% of their body weight, whereas those on a placebo lost only 1.5%
Metabolic Health Support Includes niacin, vitamin B6, and chromium to aid energy production and help regulate blood sugar levels for optimal metabolic function
Current evidence is reassuring regarding GLP-1 receptor agonists and pancreatic cancer risk
It enters circulation and activates the same gene expression cascades throughout the body affecting collagen synthesis in skin, wound healing in connective tissue, and potentially neuroprotection in the nervous system